{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:55:42Z","timestamp":1773269742606,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s1047-2797(01)00310-6","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T07:49:29Z","timestamp":1034063369000},"page":"182-196","source":"Crossref","is-referenced-by-count":75,"title":["A Review of Genetic Polymorphisms and Prostate Cancer Risk"],"prefix":"10.1016","volume":"12","author":[{"given":"Steven S","family":"Coughlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid J","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1047-2797(01)00310-6_BIB1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.2990170409","article-title":"Family history and the risk of prostate cancer","volume":"17","author":"Steinberg","year":"1990","journal-title":"Prostate."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB2","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.0.CO;2-S","article-title":"Family history of prostate cancer","volume":"70","author":"Ghadrian","year":"1997","journal-title":"Int J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5","article-title":"Familial prostate cancer in Sweden","volume":"77","author":"Gronberg","year":"1996","journal-title":"Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB5","first-page":"47","article-title":"Genetic epidemiology of prostate cancer in the Utah Mormon genealogy","volume":"1","author":"Cannon","year":"1982","journal-title":"Cancer Surv."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","article-title":"Gronberg H, Xu J, Isaacs SD, et al.","volume":"274","author":"Smith","year":"1996","journal-title":"Science."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB7","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/301879","article-title":"Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2\u201343","volume":"62","author":"Berthon","year":"1998","journal-title":"Am J Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/2477","article-title":"et.al.","volume":"20","author":"Xu","year":"1998","journal-title":"Nat Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/302342","article-title":"Analysis of chromosome 1q42.2\u201343 in 152 families with high risk of prostate cancer","volume":"64","author":"Gibbs","year":"1999","journal-title":"Am J Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/302771","article-title":"Linkage analyses at the chromosome 1 loci 1q24\u201325 (HPC1), 1q42.2\u201343 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer","volume":"66","author":"Berry","year":"2000","journal-title":"Am J Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1999.6051","article-title":"A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region","volume":"64","author":"Carpten","year":"2000","journal-title":"Genomics."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.278.15.1251","article-title":"Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus","volume":"278","author":"Gronberg","year":"1997","journal-title":"JAMA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/302447","article-title":"In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24\u201325 is restricted to families with early-onset prostate cancer","volume":"65","author":"Gronberg","year":"1999","journal-title":"Am J Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB14","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/hmg\/8.13.2437","article-title":"Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees","volume":"8","author":"Neuhausen","year":"1999","journal-title":"Hum Mol Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/bjc.1998.703","article-title":"Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC\/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign\/British Prostate Group","volume":"78","author":"Dunsmuir","year":"1998","journal-title":"Br J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.279.7.507","article-title":"Prostate cancer potentially linked to the HPC1 gene","volume":"279","author":"Walther","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.279.7.507","article-title":"Prostate cancer potentially linked to the HPC1 gene","volume":"279","author":"Laniado","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<9::AID-PROS2>3.0.CO;2-H","article-title":"Genetic variation of 3\u03b2-hydroxysteroid dehydrogenase type II in three racial\/ethnic groups","volume":"33","author":"Devgan","year":"1997","journal-title":"Prostate."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1073\/pnas.94.7.3320","article-title":"The CAG repeat within the androgen receptor gene and its relationship to prostate cancer","volume":"94","author":"Giovannucci","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(98)11282-5","article-title":"Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles","volume":"354","author":"Makridakis","year":"1999","journal-title":"USA. Lancet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB21","first-page":"4497","article-title":"Androgen metabolism and prostate cancer","volume":"58","author":"Ross","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/er.20.1.22","article-title":"Molecular genetics and epidemiology of prostate carcinoma","volume":"20","author":"Ruijter","year":"1999","journal-title":"Endoc Rev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB23","first-page":"177","article-title":"5-\u03b1- reductase inhibition and prostate cancer prevention","volume":"3","author":"Brawley","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB24","first-page":"3973","article-title":"Genetic variability of the human SRD5A2 gene","volume":"55","author":"Reichardt","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1047-2797(98)00064-7","article-title":"The emerging importance of genetics in epidemiologic research. II. Issues in study design and gene mapping","volume":"9","author":"Ellsworth","year":"1999","journal-title":"Ann Epidemiol."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000019910","article-title":"Genetic and environmental factors in prostate cancer genesis","volume":"35","author":"Ekman","year":"1999","journal-title":"Eur Urol."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB27","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","article-title":"The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function","volume":"22","author":"Chamberlain","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB28","first-page":"1937","article-title":"The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer","volume":"55","author":"Irvine","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jnci\/89.2.166","article-title":"Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor","volume":"89","author":"Ingles","year":"1997","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jnci\/86.11.872","article-title":"Re. Prostate cancer and the androgen receptor","volume":"86","year":"1994","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB31","first-page":"379","article-title":"The androgen receptor gene GGN microsatellite and prostate cancer risk","volume":"7","author":"Platz","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB32","first-page":"1194","article-title":"Polymorphic repeats in the androgen receptor gene","volume":"57","author":"Stanford","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB33","first-page":"5111","article-title":"Polymorphic CAG and GGN repeat lengths in the AR gene and prostate cancer risk","volume":"60","author":"Hsing","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjc.6690746","article-title":"CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk","volume":"81","author":"Bratt","year":"1999","journal-title":"Br J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<262::AID-PROS6>3.0.CO;2-P","article-title":"Links between genetic and environmental factors and prostate cancer risk","volume":"39","author":"Ekman","year":"1999","journal-title":"Prostate."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB36","first-page":"439","article-title":"The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer","volume":"9","author":"Lange","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y","article-title":"Androgen receptor polymorphisms","volume":"84","author":"Edwards","year":"1999","journal-title":"Int J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.ejhg.5200298","article-title":"CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population","volume":"7","author":"Correa-Cerro","year":"1999","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB39","first-page":"6479","article-title":"Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene","volume":"60","author":"Mononen","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/hmg\/2.6.820","article-title":"Unusual length polymorphism in human steroid 5\u03b1-reductase type 2 gene (SRD5A2)","volume":"2","author":"Davis","year":"1993","journal-title":"Hum Molec Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB42","first-page":"189","article-title":"A polymorphism of the 5\u03b1-reductase gene and its association with prostate cancer","volume":"6","author":"Kantoff","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB43","first-page":"1020","article-title":"A prevalent missense substitution that modulates activity of prostatic steroid 5\u03b1-reductase","volume":"57","author":"Makridakis","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB44","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/carcin\/20.9.1727","article-title":"Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)","volume":"20","author":"Lunn","year":"1999","journal-title":"Carcinogenesis."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB45","first-page":"5878","article-title":"The V89L polymorphism in the 5\u03b1-reductase type 2 gene and risk of prostate cancer","volume":"59","author":"Febbo","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB46","first-page":"1626","article-title":"Association of SRD5A2 genotype and pathological characteristics of prostate tumors","volume":"60","author":"Jaffe","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB47","first-page":"65","article-title":"Identification of a polymorphism in the ARE 1 region of the PSA promoter","volume":"40","author":"Rao","year":"1999","journal-title":"Proc Am Assoc Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB48","first-page":"839","article-title":"Susceptibility to prostate cancer","volume":"60","author":"Xue","year":"2000","journal-title":"Cancer Res."},{"issue":"1A","key":"10.1016\/S1047-2797(01)00310-6_BIB49","first-page":"197","article-title":"Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer","volume":"21","author":"Yang","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB50","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0022-5347(01)62550-3","article-title":"Vitamin D receptor polymorphisms and lethal prostate cancer","volume":"160","author":"Kibel","year":"1998","journal-title":"J Urol."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB51","first-page":"93","article-title":"Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups","volume":"6","author":"Ingles","year":"1997","journal-title":"Cancer Epidmiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB52","first-page":"385","article-title":"Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians","volume":"7","author":"Ma","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB53","first-page":"467","article-title":"Vitamin D and prostate cancer","volume":"2","author":"Corder","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00051795","article-title":"Prostate cancer and prediagnostic levels of serum vitamin D metabolites","volume":"6","author":"Braun","year":"1995","journal-title":"Cancer Causes Control."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB55","first-page":"121","article-title":"Circulating vitamin D metabolites in relation to subsequent development of prostate cancer","volume":"5","author":"Gann","year":"1996","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB56","first-page":"4108","article-title":"Association of prostate cancer with vitamin D receptor gene polymorphism","volume":"56","author":"Taylor","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB57","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1073\/pnas.89.15.6665","article-title":"Contribution of trans-acting factor alleles to normal physiological variablility","volume":"89","author":"Morrison","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB58","first-page":"1620","article-title":"Association of prostate cancer with vitamin D receptor haplotypes in African-Americans","volume":"58","author":"Ingles","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.46.467","article-title":"Vitamin D receptor gene polymorphism in Japanese patients with prostate cancer","volume":"46","author":"Furuya","year":"1999","journal-title":"Endocr J."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1098-2744(200001)27:1<18::AID-MC4>3.0.CO;2-O","article-title":"Vitamin D receptor polymorphisms and prostate cancer","volume":"27","author":"Blazer","year":"2000","journal-title":"Molec Carcinogenesis."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB61","first-page":"305","article-title":"Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population","volume":"60","author":"Habuchi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s004390051102","article-title":"Vitamin D receptor polymorphisms as markers in prostate cancer","volume":"105","author":"Correa-Cerro","year":"1999","journal-title":"Hum Genet."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jjco\/28.11.657","article-title":"Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan","volume":"28","author":"Murata","year":"1998","journal-title":"Jpn J Clin Oncol."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB64","first-page":"27","article-title":"Metabolic polymorphisms and cancer susceptibility","volume":"25","author":"Smith","year":"1995","journal-title":"Cancer surveys."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/13547509609079352","article-title":"Genetic metabolic polymorphisms and the risk of cancer","volume":"1","author":"d'Errico","year":"1996","journal-title":"Biomarkers."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB66","series-title":"Cancer epidemiology and prevention","first-page":"559","article-title":"Inherited susceptibility","author":"Strong","year":"1996"},{"key":"10.1016\/S1047-2797(01)00310-6_BIB67","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bjc.1998.685","article-title":"Expression in human prostate of drug- and carcinogen-metabolizing enzymes","volume":"78","author":"Agundez","year":"1998","journal-title":"Br J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB68","first-page":"3757","article-title":"A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women","volume":"55","author":"Taioli","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB69","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1093\/carcin\/15.12.2961","article-title":"Functional significance of different human CYP1A1 genotypes","volume":"15","author":"Crofts","year":"1994","journal-title":"Carcinogenesis."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB70","first-page":"1075","article-title":"Debrisoquine hydroxylase (CYP2D6) and prostate cancer","volume":"7","author":"Febbo","year":"1998","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB71","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/carcin\/13.6.1035","article-title":"Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility","volume":"13","author":"Wolf","year":"1992","journal-title":"Carcinogenesis."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008571-199906000-00008","article-title":"Polymorphisms in NAT2, CYP2D6, CYP2C19, and GSTP1 and their association with prostate cancer","volume":"9","author":"Wadelius","year":"1999","journal-title":"Pharmocogenetics."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB73","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/1097-0215(20000801)87:3<434::AID-IJC19>3.0.CO;2-G","article-title":"A polymorphism in the CYP17 gene is associated with prostate cancer risk","volume":"87","author":"Gsur","year":"2000","journal-title":"Int J Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB74","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008571-199910000-00010","article-title":"Prostate cancer associated with CYP17 genotype","volume":"9","author":"Wadelius","year":"1999","journal-title":"Pharmacogenetics."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB75","first-page":"5710","article-title":"Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect","volume":"60","author":"Habuchi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB76","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnci\/90.16.1225","article-title":"Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"90","author":"Rebbeck","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB77","unstructured":"Walker AH, Jaffe JM, Gunasegaram S, Cummings SA, Huang CS, Chern HD, et al. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Human Mutation, Mutation in Brief #191, URL: http:\/\/journals.wiley.com\/1059-7794\/pdf\/mutations\/191.pdf, 1998."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB78","first-page":"901","article-title":"Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients","volume":"8","author":"Paris","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB79","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(98)00311-5","article-title":"N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development","volume":"136","author":"Fukutome","year":"1999","journal-title":"Cancer Letters."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB81","first-page":"733","article-title":"Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility","volume":"6","author":"Rebbeck","year":"1997","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB82","first-page":"283","article-title":"Glutathione S-transferase-\u03bc (GSTM1) and -\u03b8 (GSTT1) genotypes in the etiology of prostate cancer","volume":"8","author":"Rebbeck","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00008469-199912000-00008","article-title":"Glutathione S-transferases as risk factors in prostate cancer","volume":"8","author":"Autrup","year":"1999","journal-title":"Eur J Cancer Prev."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/carcin\/18.4.641","article-title":"Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer","volume":"18","author":"Harries","year":"1997","journal-title":"Carcinogenesis."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB85","first-page":"F1","article-title":"Genetic epidemiology of prostate cancer","volume":"1423","author":"Narod","year":"1998","journal-title":"Biochim Biophy Acta."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB86","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3322\/canjclin.47.5.273","article-title":"Epidemiology of prostate cancer","volume":"47","author":"Haas","year":"1997","journal-title":"CA: a Cancer Journal for Clinicians."},{"issue":"suppl","key":"10.1016\/S1047-2797(01)00310-6_BIB87","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8+<1765::AID-CNCR19>3.0.CO;2-4","article-title":"The uncoupling of race and cancer genetics","volume":"83","author":"Liu","year":"1998","journal-title":"Cancer."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB88","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2105\/AJPH.90.11.1699","article-title":"Why genes don't count (for racial differences in health)","volume":"90","author":"Goodman","year":"2000","journal-title":"Am J Public Health."},{"key":"10.1016\/S1047-2797(01)00310-6_BIB89","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1200\/JCO.2000.18.11.2309","article-title":"Cancer risk and low-penetrance susceptibility genes in gene-environment interactions","volume":"18","author":"Shields","year":"2000","journal-title":"J Clin Oncol."}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279701003106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279701003106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T19:28:15Z","timestamp":1554751695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279701003106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1047279701003106"],"URL":"https:\/\/doi.org\/10.1016\/s1047-2797(01)00310-6","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}